Human BMP-7 Recombinant Protein and 1 more item

The University of Virginia awarded contract A207_PO-0453096 to Life Technologies Corporation on June 26, 2026, for the procurement of recombinant protein products. The contract encompasses two distinct line items totaling $3,148.78: Human Bone Morphogenetic Protein-7 (BMP-7) Recombinant Protein priced at $2,623.50 and Human Fibroblast Growth Factor-9 (FGF-9) Recombinant Protein from PeproTech priced at $525.28. Both products are being delivered to Josh Donovan at the University of Virginia in Virginia.

This procurement represents a research-support acquisition of specialized biological reagents for academic or institutional research purposes. The contract award reflects a straightforward purchase of one unit each of the specified recombinant proteins, which are commonly utilized in biomedical and life sciences research applications. As a purchase order-type contract, this award demonstrates the University of Virginia's engagement of Life Technologies Corporation as the prime contractor for the sourcing and delivery of these specialized laboratory materials within the Commonwealth of Virginia.